You are here

Home

Clinical Trials: Myocardial Ischemia

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Wednesday, August 14, 2019 - 12:00
Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells in Acute Myocardial Infarction
Condition:   Acute Myocardial Infarction
Intervention:   Biological: Allogeneic umbilical cord mesenchymal stem cells
Sponsor:   Ever Supreme Bio Technology Co., Ltd.
Recruiting
Posted: Friday, August 9, 2019 - 12:00
MCRcI® Stem Cell Treatment for Diffuse Coronary Artery Disease
Condition:   Coronary Artery Disease
Intervention:   Biological: MCRcI® stem cells
Sponsors:   Honya Medical Inc;   Chang Gung Memorial Hospital
Recruiting
Posted: Thursday, August 8, 2019 - 12:00
MiSaver® Stem Cell Treatment for Heart Attack (Acute Myocardial Infarction)
Condition:   Myocardial Infarction
Intervention:   Biological: MiSaver®
Sponsors:   Honya Medical Inc;   Chung Shan Medical University
Recruiting
Posted: Thursday, May 16, 2019 - 12:00
Randomized Clinical Comparison of the Combined Sirolimus Eluting and Endothelial Progenitor Cell Combo™ Stent and the Biolimus Eluting Absorbable Polymer Coated BioMatrix Alpha™ Stent in Patients Treated With Percutaneous Coronary Intervention
Condition:   Coronary Artery Disease
Interventions:   Combination Product: PCI with BioMatrix Alpha™ stent;   Combination Product: PCI with Combo™ stent
Sponsors:   Phillip Freeman;   Aarhus University Hospital;   Odense University Hospital;   OrbusNeich;   Biosensors International
Not yet recruiting
Posted: Wednesday, April 24, 2019 - 12:00
Serial Infusions of Allogeneic Mesenchymal Stem Cells in Ischemic Cardiomyopathy Patients With Left Ventricular Assist Device
Condition:   Ischemic Heart Disease
Interventions:   Biological: Human Allogeneic Mesenchymal Bone Marrow Cells (aMBMC);   Other: Placebo
Sponsor:   Rebecca Torguson
Not yet recruiting
Posted: Wednesday, April 3, 2019 - 12:00
UC-MSC Transplantation for Left Ventricular Dysfunction After AMI
Conditions:   Left Ventricular Dysfunction;   Acute Myocardial Infarction
Interventions:   Biological: UC-MSC;   Biological: Control Group
Sponsors:   Shanghai Life Science & Technology;   Shanghai Jiao Tong University Affiliated Sixth People’s Hospital
Not yet recruiting
Posted: Wednesday, January 9, 2019 - 12:00
Pericardial Matrix With Mesenchymal Stem Cells for the Treatment of Patients With Infarcted Myocardial Tissue
Condition:   Myocardial Infarction
Interventions:   Combination Product: PeriCord: Expanded and cryopreserved allogeneic umbilical cord Wharton´s jelly-derived adult mesenchymal stem cells colonized on human pericardial matrix.;   Procedure: Surgery by sternotomy
Sponsors:   Fundació Institut Germans Trias i Pujol;   Germans Trias i Pujol Hospital
Not yet recruiting
Posted: Monday, December 3, 2018 - 12:00
Short Interval Resveratrol Trial in Cardiovascular Surgery
Conditions:   Diabetes Mellitus, Type 2;   Coronary Artery Disease
Interventions:   Dietary Supplement: Trans-resveratrol;   Dietary Supplement: Placebo
Sponsors:   Maine Medical Center;   American Heart Association
Recruiting
Posted: Tuesday, November 20, 2018 - 12:00
First in Humans to Evaluate Collagen Patches With Stem Cells in Patients With Ischemic Left Ventricular Dysfunction
Condition:   Heart Failure With Reduced Ejection Fraction
Intervention:   Device: VB-C01
Sponsors:   Viscofan;   Ministerio de Ciencia e Innovación, Spain
Recruiting
Posted: Monday, March 12, 2018 - 12:00
Evaluate the Safety and Explore Efficacy of Umbilical Cord Mesenchymal Stem Cells With Acute Myocardial Infarction
Condition:   Acute Myocardial Infarction
Intervention:   Biological: Allogeneic umbilical cord mesenchymal stem cells
Sponsor:   Ever Supreme Bio Technology Co., Ltd.
Not yet recruiting

Pages